奥斯卡健康

最新新闻

• 评级变动
  Barclays Upgrades Oscar Health(OSCR.US) to Buy Rating, Raises Target Price to $35
  \u5e02\u573a\u8d44\u8baf · 2026/6/11
• Raymond James Initiates Oscar Health(OSCR.US) With Buy Rating, Announces Target Price $42
  \u5e02\u573a\u8d44\u8baf · 2026/9/19
• Piper Sandler Maintains Oscar Health(OSCR.US) With Buy Rating, Maintains Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• 评级变动
  Wells Fargo Maintains Oscar Health(OSCR.US) With Sell Rating, Maintains Target Price $11
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  Goldman Sachs Maintains Oscar Health(OSCR.US) With Hold Rating, Raises Target Price to $22
  \u5e02\u573a\u8d44\u8baf · 2026/5/11
• 评级变动
  A Quick Look at Today's Ratings for Oscar Health(OSCR.US), With a Forecast Between $25 to $39
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• Oscar Health(OSCR.US) Director Sells US$22.82 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/9/1
• 评级变动
  Barclays Maintains Oscar Health(OSCR.US) With Hold Rating, Raises Target Price to $30
  \u5e02\u573a\u8d44\u8baf · 2026/5/26
• 评级变动
  Barclays Maintains Oscar Health(OSCR.US) With Hold Rating, Raises Target Price to $21
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  Stephens Initiates Oscar Health(OSCR.US) With Hold Rating, Announces Target Price $34
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• A Quick Look at Today's Ratings for Oscar Health(OSCR.US), With a Forecast Between $30 to $49
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 评级变动
  Wolfe Research Initiates Oscar Health(OSCR.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• 评级变动
  A Quick Look at Today's Ratings for Oscar Health(OSCR.US), With a Forecast Between $11 to $18
  \u5e02\u573a\u8d44\u8baf · 2026/2/12
• 评级变动
  BofA Securities Initiates Oscar Health(OSCR.US) With Sell Rating, Announces Target Price $11
  \u5e02\u573a\u8d44\u8baf · 2026/2/11
• 评级变动
  Jefferies Upgrades Oscar Health(OSCR.US) to Hold Rating, Raises Target Price to $16
  \u5e02\u573a\u8d44\u8baf · 2026/4/20
• Raymond James Maintains Oscar Health(OSCR.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• 评级变动
  Piper Sandler Maintains Oscar Health(OSCR.US) With Buy Rating, Raises Target Price to $36
  \u5e02\u573a\u8d44\u8baf · 2026/7/29
• 评级变动
  Barclays Maintains Oscar Health(OSCR.US) With Hold Rating, Maintains Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/6/9
• 评级变动
  BofA Securities Maintains Oscar Health(OSCR.US) With Sell Rating, Raises Target Price to $13
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  Baird Maintains Oscar Health(OSCR.US) With Hold Rating, Announces Target Price $27
  \u5e02\u573a\u8d44\u8baf · 2026/8/7

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。